Michael Briskin

9.6k total citations · 3 hit papers
68 papers, 7.8k citations indexed

About

Michael Briskin is a scholar working on Immunology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Michael Briskin has authored 68 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 24 papers in Molecular Biology and 24 papers in Immunology and Allergy. Recurrent topics in Michael Briskin's work include Cell Adhesion Molecules Research (24 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and T-cell and B-cell Immunology (12 papers). Michael Briskin is often cited by papers focused on Cell Adhesion Molecules Research (24 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and T-cell and B-cell Immunology (12 papers). Michael Briskin collaborates with scholars based in United States, United Kingdom and Sweden. Michael Briskin's co-authors include Eugene C. Butcher, David P. Andrew, Ellen L. Berg, Peter J. Kilshaw, Bernhard Holzmann, Irving L. Weissman, Alf Hamann, E C Butcher, Lusijah Rott and Eugene C. Butcher and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Michael Briskin

66 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1

1993 1.2k citations Ellen L. Berg, Michael Briskin et al. Cell profile →
Lymphocyte Trafficking and Regional Immunity

1999 543 citations Eugene C. Butcher, Michael Briskin et al. profile →
Intravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver Sinusoids

2005 532 citations Frédéric Geissmann, Thomas O. Cameron et al. PLoS Biology profile →

Peers

Countries citing papers authored by Michael Briskin

Since Specialization

Citations

This map shows the geographic impact of Michael Briskin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Briskin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Briskin more than expected).

Fields of papers citing papers by Michael Briskin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Briskin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Briskin. The network helps show where Michael Briskin may publish in the future.

Co-authorship network of co-authors of Michael Briskin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Briskin. A scholar is included among the top collaborators of Michael Briskin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Briskin. Michael Briskin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 2914: AI/ML-driven discovery of CTHRC1, collagen triple helix repeat-containing 1, a novel proteoglycan for stroma + tumor targeting and delivery of 4-1BB costimulation 2024 ·Cancer Research ·Christopher J. Harvey, Elizabeth A. Koch, (unknown), (unknown), (unknown), Kerry White, Reza Saberianfar, (unknown), (unknown), Michael Briskin	0
2	ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models 2020 ·PLoS ONE ·(unknown), Kutlu G. Elpek, Ellen Duong, (unknown), Martin Fan, Calvin M. Johnson, Matthew Wallace, (unknown), Stephen L. Sazinsky, (unknown), Chengyi J. Shu, Sriram Sathyanarayanan, (unknown), Tyler R. Simpson, Monica Gostissa, Michael Briskin, (unknown), Jennifer S. Michaelson, Christopher J. Harvey	23
3	Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues 2005 ·The Journal of Experimental Medicine ·J. Rodrigo Mora, Guiying Cheng, Dominic Picarella, Michael Briskin, Natasha Buchanan, Ulrich H. von Andrian	248
4	Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease 2005 ·Clinical & Experimental Allergy ·Angela Morgan, C. Guillén, Fiona A. Symon, Tam T. Huynh, M A Berry, James Entwisle, Michael Briskin, Ian Pavord, Andrew J. Wardlaw	72
5	Intravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver Sinusoids breakdown → 2005 ·PLoS Biology ·Frédéric Geissmann, Thomas O. Cameron, Stéphane Sidobre, (unknown), Mitchell Kronenberg, Michael Briskin, Michael L. Dustin, Dan R. Littman	532
6	Hepatic Endothelial CCL25 Mediates the Recruitment of CCR9+ Gut-homing Lymphocytes to the Liver in Primary Sclerosing Cholangitis 2004 ·The Journal of Experimental Medicine ·Bertus Eksteen, Allister J. Grant, Alice Miles, Stuart M. Curbishley, Patricia F. Lalor, Stefan G. Hübscher, Michael Briskin, Mike Salmon, David Adams	245
7	FcεRI-dependent gene expression in human mast cells is differentially controlled by T helper type 2 cytokines 2003 ·Journal of Allergy and Clinical Immunology ·José M. Lora, Amal Al‐Garawi, Michael D. Pickard, Kursteen S. Price, (unknown), (unknown), Martin R. Hodge, José-Carlos Gutierrez-Ramos, Michael Briskin, Joshua A. Boyce	20
8	The Chemokine Stromal Cell-Derived Factor-1α Modulates α4β7 Integrin-Mediated Lymphocyte Adhesion to Mucosal Addressin Cell Adhesion Molecule-1 and Fibronectin 2002 ·The Journal of Immunology ·Natalia Wright, Andrés Hidalgo, José Miguel Rodríguez‐Frade, Silvia F. Soriano, Mario Mellado, (unknown), Michael Briskin, Joaquı́n Teixidó	68
9	Bovine γδ T Cell Subsets Express Distinct Patterns of Chemokine Responsiveness and Adhesion Molecules: A Mechanism for Tissue-Specific γδ T Cell Subset Accumulation 2002 ·The Journal of Immunology ·Eric Wilson, Jodi F. Hedges, Eugene C. Butcher, Michael Briskin, Mark A. Jutila	49
10	Hepatic Expression of Secondary Lymphoid Chemokine (CCL21) Promotes the Development of Portal-Associated Lymphoid Tissue in Chronic Inflammatory Liver Disease 2002 ·American Journal Of Pathology ·Allister J. Grant, (unknown), Jalal Ahmed-Choudhury, Gary Reynolds, David G. Jackson, Michael Briskin, Lijun Wu, Stefan G. Hübscher, David Adams	131
11	Expression Cloning of the STRL33/BONZO/TYMSTR Ligand Reveals Elements of CC, CXC, and CX3C Chemokines 2001 ·The Journal of Immunology ·(unknown), Susan Carr Zondlo, Kristine Murphy, (unknown), Dulce Soler, (unknown), David P. Andrew, Lijun Wu, Michael Briskin	258
12	Immune cell trafficking in uterus and early life is dominated by the mucosal addressin MAdCAM-1 in humans 2001 ·Gastroenterology ·(unknown), Kalle Alanen, Seija Grénman, Michael Briskin, Eugene C. Butcher, Sirpa Jalkanen	39
13	The α4 Integrin Subunit Tyr187 Has a Key Role in α4β7-Dependent Cell Adhesion 2000 ·Journal of Biological Chemistry ·(unknown), Mercedes Guerrero-Esteo, Michael Briskin, Joaquı́n Teixidó	12
14	Characterization of hyaluronan synthase from a human glioma cell line 1998 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·T Asplund, Jonas Brinck, Masanobu Suzuki, Michael Briskin, Paraskevi Heldin	39
15	Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. 1997 ·PubMed Central ·Michael Briskin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	457
16	Functional Cloning of the cDNA for a Human Hyaluronan Synthase 1996 ·Journal of Biological Chemistry ·(unknown), Paraskevi Heldin, Eugene C. Butcher, Tadashi Yoshino, Michael Briskin	133
17	Phenotype, and migration properties of three major subsets of tissue homing T cells in sheep 1996 ·European Journal of Immunology ·Charles R. Mackay, David P. Andrew, Michael Briskin, D J Ringler, Eugene C. Butcher	73
18	Structural requirements for mucosal vascular addressin binding to its lymphocyte receptor α 4 β 7. Common themes among integrin-Ig family interactions 1996 ·The Journal of Immunology ·Michael Briskin, L S Rott, E C Butcher	53
19	Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes. 1994 ·The Journal of Immunology ·David J. Erle, Michael Briskin, E C Butcher, Ángeles García-Pardo, A I Lazarovits, Mark Tidswell	304
20	α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1 breakdown → 1993 ·Cell ·(unknown), Ellen L. Berg, Michael Briskin, David P. Andrew, Peter J. Kilshaw, Bernhard Holzmann, Irving L. Weissman, Alf Hamann, Eugene C. Butcher	1209

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact